Different components in human serum inhibit multiplication of Cryptococcus neoformans and enhance fluconazole activity.

Antimicrobial Agents and Chemotherapy
F NassarD A Stevens

Abstract

The inhibitory effect of human serum on the multiplication of Cryptococcus neoformans and the interaction with fluconazole were studied. Compared with cryptococcal multiplication in RPMI 1640 medium alone, 5% human serum in medium inhibited multiplication by 76% +/- 6% (n = 8). The inhibitory effect of human serum was donor independent, [corrected] heat stable (56 degrees C, 30 min), and not due to albumin or globulin. Bovine and murine sera were not inhibitory at that concentration. A fungistatic concentration of fluconazole (5.0 micrograms/ml) in medium plus 5% human serum resulted in 40% +/- 5% (n = 8) killing (reduction of inoculum CFU) in a 24-h assay. Bovine or murine sera did not have the enhancing effect, and this human serum activity was heat stable and donor independent. At 2.5 micrograms of fluconazole per ml, fungistasis by fluconazole plus human serum was significantly greater than with either alone. Higher serum concentrations [corrected] potentiated fluconazole more. At higher fluconazole concentrations (e.g., 20 micrograms/ml) fluconazole alone could kill, but serum potentiated this. A fluconazole-resistant isolate (MIC, 100 micrograms/ml) was not killed by fluconazole (5.0 micrograms/ml) in 5% human serum, but ...Continue Reading

References

Dec 11, 1992·Journal of Clinical Microbiology·A Espinel-IngroffM G Rinaldi
Sep 1, 1986·Antimicrobial Agents and Chemotherapy·T E Rogers, J N Galgiani
Dec 5, 1985·The New England Journal of Medicine·K Godfrey
Jan 1, 1993·Antimicrobial Agents and Chemotherapy·R A FromtlingG D Roberts

❮ Previous
Next ❯

Citations

May 15, 1971·Experientia·B W BycroftA Hassanali-Walji
Nov 16, 2001·Antimicrobial Agents and Chemotherapy·T WoykeR K Pettit
Jan 18, 2005·Clinical Microbiology Reviews·Pranab K MukherjeeMahmoud A Ghannoum
Apr 13, 2010·Eukaryotic Cell·Kerstin Voelz, Robin C May
May 19, 2000·Infection and Immunity·S SridharD A Stevens
Dec 19, 2001·Infection and Immunity·Anna H T GiffordMargo M Moore
Jun 1, 1996·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·E A FieldC A Hitchcock
Jul 1, 1997·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·P W NelsonJ H Rex
Jun 29, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·T F Patterson
Sep 29, 2005·Hematology·Vladimir Krcmery, Pavol Beno
Dec 17, 2009·Clinical Pharmacokinetics·Andrew A UdyJeffrey Lipman
Feb 24, 2001·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·S W ReddingT F Patterson
Nov 7, 2006·Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology·Ann R HolmesRichard D Cannon
Feb 16, 2011·Drugs·Chrysanthi L SkevakiAthanassios Tsakris
Jan 11, 2005·Current Opinion in Infectious Diseases·David Andes
Oct 13, 2006·Current Opinion in Infectious Diseases·S L Croft
Aug 15, 2001·Pharmacotherapy·H L Hoffman, M A Pfaller
Aug 15, 2001·Pharmacotherapy·M E Klepser
Dec 4, 2004·Biological & Pharmaceutical Bulletin·Toshitsugu TaguriIsao Kouno
Nov 2, 2006·Biological & Pharmaceutical Bulletin·Toshitsugu TaguriIsao Kouno
Jan 5, 2007·Biological & Pharmaceutical Bulletin·Hui ShenYuan-Ying Jiang
Apr 20, 1995·The New England Journal of Medicine·J T Reynolds
Oct 2, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John H Rex, Michael A Pfaller
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jimmy L Hawkins, Larry M Baddour
Dec 31, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter G PappasUNKNOWN Infectious Diseases Society of America
Dec 16, 2006·Internal Medicine·Masafumi SekiShigeru Kohno
Jan 29, 2002·Microbial Pathogenesis·Steven Giles, Charles Czuprynski
Nov 4, 2006·Journal of Inflammation·Angela DjananiChristian J Wiedermann
Jan 12, 2007·PLoS Medicine·Maha-Hamadien AbdullaConor R Caffrey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.